Diagnostic Accuracy of Saline Sonohystrography vs. 3D Transvaginal Ultrasound for Cesarean Scar Defect Assessment
Launched by CAIRO UNIVERSITY · Aug 10, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different imaging techniques to see which one is better at detecting problems with the uterus after having a cesarean section, specifically looking for issues called cesarean scar defects. The two methods being compared are saline sonohystography, which is considered the standard method, and a newer technique called 3D transvaginal ultrasound. This research aims to help doctors better understand how common these defects are and how they appear in women who have had cesarean deliveries.
To participate in this trial, women aged 20 to 45 who have had between one to three cesarean sections and whose last surgery was between 6 months and 5 years ago may be eligible. However, women who are currently pregnant, have certain infections, or have had recent surgeries or complications will not be able to take part. If eligible, participants can expect to undergo imaging tests to help doctors evaluate their uterine health. This study is important because it could lead to improved ways to assess and manage complications after cesarean sections, ultimately helping women receive better care.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 20 and 45 years
- • Previous 1-3 cesarean sections
- • The duration from the last cesarean section ranging from 6 months to 5 years.
- Exclusion Criteria:
- • Pregnancy (Positive pregnancy test)
- • Recent pelvic infection.
- • Active pelvic infection.
- • Recent surgery on the tubes or the uterus.
- • Active vaginal bleeding.
- • Menstruation.
- • Suspected malignancy.
- • Intrauterine device in situ.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported